TY - JOUR
T1 - EHDS are serine phosphoproteins
T2 - EHD1 phosphorylation is enhanced by serum stimulation
AU - Fichtman, Boris
AU - Ravid, Liat
AU - Rapaport, Debora
AU - Horowitz, Mia
N1 - Funding Information:
Acknowledgements. This work was partially supported by the Jacqueline Seroussi Memorial Foundation for Cancer Research, the Kodesh Institute for Research on Cancer Development and Prevention and the German-Israeli BioDisc program (to Mia Horowitz).
PY - 2008/12
Y1 - 2008/12
N2 - Endocytic processes are mediated by multiple protein-protein interacting modules and regulated by phosphorylation and dephosphorylation. The Eps15 homology domain containing protein 1 (EHD1) has been implicated in regulating recycling of proteins, internalized both in clathrin-dependent and clathrin-independent endocytic pathways, from the recycling compartment to the plasma membrane. EHD1 was found in a complex with clathrin, adaptor protein complex-2 (AP-2) and insulin-like growth factor-1 receptor (IGF-1R), and was shown to interact with Rabenosyn-5, SNAP29, EHBP1 (EH domain binding protein 1) and syndapin I and II. In this study, we show that EHD1, like the other human EHDs, undergoes serine-phosphorylation. Our results also indicate that EHD1 is a serum-inducible serine-phosphoprotein and that PKC (protein kinase C) is one of its kinases. In addition, we show that inhibitors of clathrin-mediated endocytosis decrease EHD1 phosphorylation, while inhibitors of caveolin-mediated endocytosis do not affect EHD1 phosphorylation. The results of experiments in which inhibitors of endocytosis were employed strongly suggest that EHD1 phosphorylation occurs between early endosomes and the endocytic recycling compartment.
AB - Endocytic processes are mediated by multiple protein-protein interacting modules and regulated by phosphorylation and dephosphorylation. The Eps15 homology domain containing protein 1 (EHD1) has been implicated in regulating recycling of proteins, internalized both in clathrin-dependent and clathrin-independent endocytic pathways, from the recycling compartment to the plasma membrane. EHD1 was found in a complex with clathrin, adaptor protein complex-2 (AP-2) and insulin-like growth factor-1 receptor (IGF-1R), and was shown to interact with Rabenosyn-5, SNAP29, EHBP1 (EH domain binding protein 1) and syndapin I and II. In this study, we show that EHD1, like the other human EHDs, undergoes serine-phosphorylation. Our results also indicate that EHD1 is a serum-inducible serine-phosphoprotein and that PKC (protein kinase C) is one of its kinases. In addition, we show that inhibitors of clathrin-mediated endocytosis decrease EHD1 phosphorylation, while inhibitors of caveolin-mediated endocytosis do not affect EHD1 phosphorylation. The results of experiments in which inhibitors of endocytosis were employed strongly suggest that EHD1 phosphorylation occurs between early endosomes and the endocytic recycling compartment.
KW - EH domain
KW - EHD1
KW - Endocytosis
KW - Phosphorylation
UR - http://www.scopus.com/inward/record.url?scp=58149288343&partnerID=8YFLogxK
U2 - 10.2478/s11658-008-0027-4
DO - 10.2478/s11658-008-0027-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:58149288343
SN - 1425-8153
VL - 13
SP - 632
EP - 648
JO - Cellular and Molecular Biology Letters
JF - Cellular and Molecular Biology Letters
IS - 4
ER -